GDNF family receptors (provisional nomenclature, ENSFM00500000269996) are extrinsic tyrosine kinase receptors. Ligand binding to the extracellular domain of the glycosylphosphatidylinositol-linked cell-surface receptors (tabulated below) activates a transmembrane tyrosine kinase enzyme, Ret (Rearranged during transfection, ENSG00000165731). The endogenous ligands are typically dimeric, linked through disulphide bridges: glial cell-derived neurotrophic factor (GDNF, 211 aa, ENSG00000168621); neurturin (NRTN, 197 aa, ENSG00000171119); artemin (ARTN, 237 aa, ENSG00000117407) and PSPN (PSPN, 156 aa, ENSG00000125650).
Unless otherwise stated all data refer to the human proteins. Gene information is provided for human (Hs), mouse (Mm) and rat (Rn).
|
GDNF family receptor α1 Show »« Hide
|
|||||||||||||||
|
GDNF family receptor α2 Show »« Hide
|
|||||||||||||||
|
GDNF family receptor α3 Show »« Hide
|
|||||||||||||||
|
GDNF family receptor α4 Show »« Hide
|
Bespalov, MM; Saarma, M. (2007) GDNF family receptor complexes are emerging drug targets. Trends Pharmacol. Sci., 28 (2): 68-74. [PMID:17218019]
Carnicella, S; Ron, D. (2009) GDNF--a potential target to treat addiction. Pharmacol. Ther., 122 (1): 9-18. [PMID:19136027]
Ernsberger, U. (2008) The role of GDNF family ligand signalling in the differentiation of sympathetic and dorsal root ganglion neurons. Cell Tissue Res., 333 (3): 353-71. [PMID:18629541]
Paratcha, G; Ledda, F. (2008) GDNF and GFRalpha: a versatile molecular complex for developing neurons. Trends Neurosci., 31 (8): 384-91. [PMID:18597864]
Rangasamy, SB; Soderstrom, K; Bakay, RA; Kordower, JH. (2010) Neurotrophic factor therapy for Parkinson's disease. Prog. Brain Res., 184: 237-64. [PMID:20887879]
Schueler-Furman, O; Glick, E; Segovia, J; Linial, M. (2006) Is GAS1 a co-receptor for the GDNF family of ligands?. Trends Pharmacol. Sci., 27 (2): 72-7. [PMID:16406089]
1. Klein, RD; Sherman, D; Ho, WH; Stone, D; Bennett, GL; Moffat, B; Vandlen, R; Simmons, L; Gu, Q; Hongo, JA; et al.. (1997) A GPI-linked protein that interacts with Ret to form a candidate neurturin receptor. Nature, 387 (6634): 717-21. [PMID:9192898]
2. Mologni, L; Sala, E; Cazzaniga, S; Rostagno, R; Kuoni, T; Puttini, M; Bain, J; Cleris, L; Redaelli, S; Riva, B; et al.. (2006) Inhibition of RET tyrosine kinase by SU5416. J. Mol. Endocrinol., 37 (2): 199-212. [PMID:17032739]
3. Treanor, JJ; Goodman, L; de Sauvage, F; Stone, DM; Poulsen, KT; Beck, CD; Gray, C; Armanini, MP; Pollock, RA; Hefti, F; et al.. (1996) Characterization of a multicomponent receptor for GDNF. Nature, 382 (6586): 80-3. [PMID:8657309]
|
@GuidetoPHARM Like us on Facebook Privacy and Cookie Policy |


Inhibitors of other receptor tyrosine kinases, such as semaxinib, which inhibits VEGF receptor function, may also inhibit Ret function [2]. Mutations of Ret and GDNF genes may be involved in Hirschsprung's disease, which is characterized by the absence of intramural ganglion cells in the hindgut, often resulting in intestinal obstruction.